UAE GDP: AED 2.03T ▲ 5.7% | Non-Oil GDP Share: 84.3% ▼ -5.2pp | FDI Inflows: $45.6B ▲ 48.7% | GDP Growth: 4.0% ▲ -0.3pp vs 2023 | Inflation: 1.7% ▼ +0.0pp vs 2023 | Female Participation: 55.1% ▲ +0.6pp vs 2023 | Population: 11.0M ▲ 4.8% | Emiratisation Rate: 12.5% ▲ 2.1pp | Global Competitiveness: #7 ▲ 3 places | Clean Energy Capacity: 7.2 GW ▲ 18.4% | ADX Index: 9,842 ▲ 4.7% | DFM Index: 4,621 ▲ 6.2% | UAE GDP: AED 2.03T ▲ 5.7% | Non-Oil GDP Share: 84.3% ▼ -5.2pp | FDI Inflows: $45.6B ▲ 48.7% | GDP Growth: 4.0% ▲ -0.3pp vs 2023 | Inflation: 1.7% ▼ +0.0pp vs 2023 | Female Participation: 55.1% ▲ +0.6pp vs 2023 | Population: 11.0M ▲ 4.8% | Emiratisation Rate: 12.5% ▲ 2.1pp | Global Competitiveness: #7 ▲ 3 places | Clean Energy Capacity: 7.2 GW ▲ 18.4% | ADX Index: 9,842 ▲ 4.7% | DFM Index: 4,621 ▲ 6.2% |

Healthcare Quality Index Tracker: Top 15 Target

Tracking the UAE's progress toward a top-15 global healthcare quality ranking under We the UAE 2031. This tracker measures health system outcomes, access metrics, and institutional quality against the programme's wellbeing targets.

The top-15 global healthcare quality target requires the UAE to close the gap with advanced health systems in clinical outcomes, access, and efficiency. Starting from approximately 29th globally on the Healthcare Access and Quality Index in 2022, the target demands sustained improvement in chronic disease management, preventive care, specialist capacity, and health data infrastructure.

Target vs. Actual Performance

Metric2022202320242025 (est.)Target
HAQ Index Rank29272422Top 15
Life Expectancy (years)78.278.578.879.180.5+
Infant Mortality (per 1,000)5.24.94.64.43.0
Hospital Bed Density (per 1,000)1.31.41.51.62.5
Physician Density (per 1,000)2.62.72.93.03.5
Healthcare Spend (% of GDP)4.2%4.4%4.6%4.8%5.5%

Facility Expansion Tracker

ProjectCapacityLocationStatus
Cleveland Clinic Abu Dhabi Phase II+200 bedsAbu DhabiUnder construction
Sheikh Shakhbout Medical City expansion+150 bedsAbu DhabiOperational 2025
Mediclinic Parkview expansion+120 bedsDubaiPlanning
NMC Royal Hospital Sharjah+250 bedsSharjahOperational 2024
RAK Hospital modernisation+80 bedsRas Al KhaimahUnder construction
Tawam Hospital digital upgradeDigital infrastructureAl AinImplementation

Progress Rate Analysis

The UAE has made notable progress on the HAQ Index, climbing from 29th to an estimated 22nd between 2022 and 2025. This improvement reflects both investment in flagship medical facilities and regulatory reforms including mandatory health insurance expansion, clinical quality standards enforcement, and medical tourism infrastructure development.

The gains have been strongest in acute care and specialty services, where Abu Dhabi and Dubai now offer treatment capabilities comparable to leading European centres. Cleveland Clinic Abu Dhabi, Mayo Clinic collaboration agreements, and King’s College Hospital Dubai represent institutional quality anchors that elevate the system’s upper tier.

The challenge lies in population-level health metrics. Chronic disease prevalence — particularly diabetes (affecting approximately 16 per cent of the adult population) and obesity (31 per cent) — places upward pressure on mortality statistics and drags composite health indices. Preventive care and public health outcomes require behaviour change at scale, which is slower to achieve than facility construction.

Risk Factors

RiskSeverityImpact
Chronic disease prevalenceHighCaps outcome improvement on composite indices
Healthcare workforce retentionMediumHigh turnover among expatriate medical staff
Insurance coverage gapsMediumSegments of population underserved
Primary care capacityMediumOver-reliance on hospital-based delivery
Mental health service deficitMediumEmerging demand outpacing supply

Outlook

A top-15 HAQ ranking by 2031 is achievable but requires acceleration in primary care, chronic disease management, and population health outcomes alongside continued facility investment. The UAE’s healthcare strategy correctly identifies digital health, telemedicine, and genomics research as differentiators, but the basic public health metrics — diabetes prevalence, lifestyle disease burden, preventive screening rates — represent the binding constraint. The ranking trajectory suggests a top-15 position is realistic by 2029-2030 if current reform pace continues and chronic disease interventions show measurable results.

Current Assessment: On Track — requires acceleration in preventive care and chronic disease management.